Precision BioSciences, Inc. (DTIL)
Last updated: 2026-10-21 16:30:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Precision BioSciences, Inc. (DTIL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $6.68, with a market capitalization of $170.85M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.53 to $9.62. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$170.85M | |
$6.62 | |
$710.11 | |
$3.53 | |
$6.56 | |
135.13K | |
261.66K | |
-- | |
$9.62 | |
$3.53 | |
-- | |
-- |
Precision BioSciences, Inc. (DTIL) Stock Price Today
Precision BioSciences, Inc. (DTIL) is currently trading at $6.68 as of 2026-10-21 16:29:00, up 1.83% ($0.12) from the previous close of $6.56
During today's regular trading session, DTIL has traded between $3.53 and $710.11, with a trading volume of 135.13K shares. The current price is near the lower end of today's range.
Precision BioSciences, Inc. (DTIL) 7-Day Stock Price Change
Over the past seven days, Precision BioSciences, Inc. (DTIL) moved from $6.53 to $6.68, representing a gain of 2.30% ($0.15).
The stock traded between $5.72 and $6.79 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 255.17 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
DTIL 52-Week Price Position
Position in Range: 51.7%
DTIL is currently trading at $6.68, placing it 51.7% of the way from its 52-week low of $3.53 to its 52-week high of $9.62. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Precision BioSciences, Inc. (DTIL)?
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
Precision BioSciences, Inc. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 67 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Precision BioSciences, Inc. (DTIL) Stock on MEXC
Eligible investors can buy real shares of Precision BioSciences, Inc. (DTIL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Precision BioSciences, Inc. (DTIL) stock price today?
2.Is DTIL stock going up or down today?
3.What is DTIL pre-market price?
4.What is DTIL after-hours price?
5.Is DTIL stock trading now?
6.Where does DTIL sit relative to its 52-week high and low?
7.What sector is Precision BioSciences, Inc. in?
8.What is Precision BioSciences, Inc.'s market capitalization and where is it listed?
9.How is DTIL valued in terms of P/E ratio and EPS?
10.Does Precision BioSciences, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
DTIL Stock Calculator
Estimate the value between DTIL shares and USD.
DTIL Shares to USD
1.00 DTIL shares = 6.68 USD
Calculations are estimates based on the latest available price and are for reference only.


